• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI
Click for more information
1.39% 7.1¢

NEUROTECH INTERNATIONAL LIMITED - Charts / Financials

Market Cap $72.23M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

refresh Created with Sketch. REFRESH
Last update - 15.34pm 23/08/2024 (20 minute delay) ?
Day
Open 7.2¢   Day High 7.2¢   Day Low 7.1¢
Daily Volume 3761406
Bids   Sellers
Number Price Volume   Number Price Volume
1 7.1¢ 17129   2 7.3¢ 176986

Directors & Senior Management

Dr. Alexandra Andrews Chief Operating Officer
Dr. Thomas Duthy Executive Director
Mr. Gerald Quigley Director of Public Relations, Non-Executive Director
Assoc. Prof. Carolyn Ellaway Chief Medical Officer
Mrs. Erlyn Dawson Joint Company Secretary
Ms. Alessandra Gauvin Joint Company Secretary
Mr. Mark Davies Non-Executive Chairman of the Board
Mr. Robert Maxwell Johnston Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
7.1¢ 		Change
-0.001(1.39%) 		Mkt cap ! $72.23M
Open High Low Value Volume
7.2¢ 7.2¢ 7.1¢ $270.0K 3.761M

Buyers (Bids)

No. Vol. Price($)
1 17129 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 176986 2
View Market Depth
Last trade - 15.35pm 23/08/2024 (20 minute delay) ?
Last
7.2¢ 		  Change
-0.001 ( 0.69 %)
Open High Low Volume
7.2¢ 7.2¢ 7.1¢ 158734
Last updated 15.34pm 23/08/2024 ?

Top Stories

Reporting wrap: Inghams, Accent, Mayne Pharma

Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
Raiden gears up for exploration in final quarter of 2024 Raiden Resources Ltd - which is exploration for a multiplicity of minerals in the Pilbara region of WA - is looking ahead to a busy schedule.
The Rising Tide: How institutional adoption is shaping the future of crypto This year's institutional demand for Bitcoin supports stability & credibility for the asset class. We look at what's happened since crypto ETFs were approved in the US & what that means for Australian investors.
How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign Strategic Energy Resources is 4 holes into a 40-hole RC drill campaign at its Achilles 1 copper-gold target in the Cobar Basin of NSW.
The business of sport: Warren Tredrea's take on this week's news Former Port Adelaide AFL star – turned media personality – Warren Tredrea and co-host Jack Hudson explore money in sport.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.